Source: The New York Times

Mylan: Well: EpiPen Price Rise Sparks Concern for Allergy Sufferers

A steep increase in the price of a lifesaving injection device for allergies has parents worried they won't be able to afford the drug for children heading back to school.

Read full article »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Based on data from Mylan's latest SEC filings

Annual Revenue

Based on data from Mylan's latest SEC filings

Employees

Heather Bresch's photo - CEO of Mylan

CEO

Heather Bresch

CEO Approval Rating

65/100

Mylan engages in the development, manufacture and distribution of generic medical products.

Mylan's headquarters is locat...
Read more